APO Research

APO RESEARCH · REPORT

Pet Obesity Management

Selected research

Market Outlook & Growth Opportunities

Global Pet Obesity Management Market Outlook and Growth Opportunities 2026

Market perspective

The global Pet Obesity Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Obesity Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Obesity Management market include Zoetis Inc (Pfizer), Novo Nordisk A/S, Vivaldis, Royal Canin, Pedigree Petfoods, Hill's Pet Nutrition, Inc and Auxthera LLC, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pet Obesity Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Obesity Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Obesity Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pet Obesity Management market.

Pet Obesity Management Segment by Company

Zoetis Inc (Pfizer)

Novo Nordisk A/S

Vivaldis

Royal Canin

Pedigree Petfoods

Hill's Pet Nutrition, Inc

Auxthera LLC

Pet Obesity Management Segment by Type

Drugs

Food Supplements

Pet Obesity Management Segment by Application

Pet Specialty Stores

E-commerce

Others

Pet Obesity Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Obesity Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pet Obesity Management key companies, revenue, market share, and recent developments.

3. To split the Pet Obesity Management breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pet Obesity Management market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Obesity Management significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Obesity Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Obesity Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Obesity Management industry.

Chapter 3: Detailed analysis of Pet Obesity Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pet Obesity Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pet Obesity Management in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Obesity Management Industry Trends Table 2. Pet Obesity Management Industry Drivers Table 3. Pet Obesity Management Industry Opportunities and Challenges Table 4. Pet Obesity Management Industry Restraints Table 5. Global Pet Obesity Management Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Obesity Management Revenue Share by Company (2021-2026) Table 7. Global Pet Obesity Management Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pet Obesity Management Key Company Manufacturing Base & Headquarters Table 9. Global Pet Obesity Management Company, Product Type & Application Table 10. Global Pet Obesity Management Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pet Obesity Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drugs Table 15. Significant Companies of Food Supplements Table 16. Global Pet Obesity Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pet Obesity Management Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pet Obesity Management Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pet Obesity Management Sales Value Share by Type (2021-2026) Table 20. Global Pet Obesity Management Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pet Specialty Stores Table 22. Significant Companies of E-commerce Table 23. Significant Companies of Others Table 24. Global Pet Obesity Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pet Obesity Management Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pet Obesity Management Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pet Obesity Management Sales Value Share by Application (2021-2026) Table 28. Global Pet Obesity Management Sales Value Share by Application (2027-2032) Table 29. Global Pet Obesity Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pet Obesity Management Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pet Obesity Management Sales Value Share by Region (2021-2026) Table 32. Global Pet Obesity Management Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pet Obesity Management Sales Value Share by Region (2027-2032) Table 34. Global Pet Obesity Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pet Obesity Management Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pet Obesity Management Sales Value Market Share by Country (2021-2026) Table 37. Global Pet Obesity Management Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pet Obesity Management Sales Value Market Share by Country (2027-2032) Table 39. Zoetis Inc (Pfizer) Company Information Table 40. Zoetis Inc (Pfizer) Business Overview Table 41. Zoetis Inc (Pfizer) Pet Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Zoetis Inc (Pfizer) Pet Obesity Management Product Portfolio Table 43. Zoetis Inc (Pfizer) Recent Development Table 44. Novo Nordisk A/S Company Information Table 45. Novo Nordisk A/S Business Overview Table 46. Novo Nordisk A/S Pet Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Novo Nordisk A/S Pet Obesity Management Product Portfolio Table 48. Novo Nordisk A/S Recent Development Table 49. Vivaldis Company Information Table 50. Vivaldis Business Overview Table 51. Vivaldis Pet Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Vivaldis Pet Obesity Management Product Portfolio Table 53. Vivaldis Recent Development Table 54. Royal Canin Company Information Table 55. Royal Canin Business Overview Table 56. Royal Canin Pet Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Royal Canin Pet Obesity Management Product Portfolio Table 58. Royal Canin Recent Development Table 59. Pedigree Petfoods Company Information Table 60. Pedigree Petfoods Business Overview Table 61. Pedigree Petfoods Pet Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Pedigree Petfoods Pet Obesity Management Product Portfolio Table 63. Pedigree Petfoods Recent Development Table 64. Hill's Pet Nutrition, Inc Company Information Table 65. Hill's Pet Nutrition, Inc Business Overview Table 66. Hill's Pet Nutrition, Inc Pet Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Hill's Pet Nutrition, Inc Pet Obesity Management Product Portfolio Table 68. Hill's Pet Nutrition, Inc Recent Development Table 69. Auxthera LLC Company Information Table 70. Auxthera LLC Business Overview Table 71. Auxthera LLC Pet Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Auxthera LLC Pet Obesity Management Product Portfolio Table 73. Auxthera LLC Recent Development Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Pet Obesity Management Product Image Figure 2. Global Pet Obesity Management Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Obesity Management Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Obesity Management Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drugs Image Figure 8. Food Supplements Image Figure 9. Global Pet Obesity Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pet Obesity Management Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pet Obesity Management Sales Value Share by Type (2021-2032) Figure 12. Pet Specialty Stores Image Figure 13. E-commerce Image Figure 14. Others Image Figure 15. Global Pet Obesity Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pet Obesity Management Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pet Obesity Management Sales Value Share by Application (2021-2032) Figure 18. Global Pet Obesity Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pet Obesity Management Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pet Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pet Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pet Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pet Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pet Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pet Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pet Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pet Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pet Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pet Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pet Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pet Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pet Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Food Supplements
Applications
  • Pet Specialty Stores
  • E-commerce
  • Others
Companies covered
  • Zoetis Inc (Pfizer)
  • Novo Nordisk A/S
  • Vivaldis
  • Royal Canin
  • Pedigree Petfoods
  • Hill's Pet Nutrition, Inc
  • Auxthera LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Obesity Management Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Obesity Management Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pet Obesity Management Market Dynamics
  1. 2.1 Pet Obesity Management Industry Trends
  2. 2.2 Pet Obesity Management Industry Drivers
  3. 2.3 Pet Obesity Management Industry Opportunities and Challenges
  4. 2.4 Pet Obesity Management Industry Restraints
3 Pet Obesity Management Market by Company
  1. 3.1 Global Pet Obesity Management Company Revenue Ranking in 2025
  2. 3.2 Global Pet Obesity Management Revenue by Company (2021-2026)
  3. 3.3 Global Pet Obesity Management Company Ranking (2024-2026)
  4. 3.4 Global Pet Obesity Management Company Manufacturing Base and Headquarters
  5. 3.5 Global Pet Obesity Management Company Product Type and Application
  6. 3.6 Global Pet Obesity Management Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pet Obesity Management Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pet Obesity Management Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pet Obesity Management Market by Type
  1. 4.1 Pet Obesity Management Type Introduction
  2. 4.1.1 Drugs
  3. 4.1.2 Food Supplements
  4. 4.2 Global Pet Obesity Management Sales Value by Type
  5. 4.2.1 Global Pet Obesity Management Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pet Obesity Management Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pet Obesity Management Sales Value Share by Type (2021-2032)
5 Pet Obesity Management Market by Application
  1. 5.1 Pet Obesity Management Application Introduction
  2. 5.1.1 Pet Specialty Stores
  3. 5.1.2 E-commerce
  4. 5.1.3 Others
  5. 5.2 Global Pet Obesity Management Sales Value by Application
  6. 5.2.1 Global Pet Obesity Management Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Obesity Management Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pet Obesity Management Sales Value Share by Application (2021-2032)
6 Pet Obesity Management Regional Value Analysis
  1. 6.1 Global Pet Obesity Management Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Obesity Management Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pet Obesity Management Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pet Obesity Management Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Obesity Management Sales Value (2021-2032)
  7. 6.3.2 North America Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pet Obesity Management Sales Value (2021-2032)
  10. 6.4.2 Europe Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pet Obesity Management Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pet Obesity Management Sales Value (2021-2032)
  16. 6.6.2 South America Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pet Obesity Management Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
7 Pet Obesity Management Country-level Value Analysis
  1. 7.1 Global Pet Obesity Management Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Obesity Management Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pet Obesity Management Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pet Obesity Management Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pet Obesity Management Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pet Obesity Management Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pet Obesity Management Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pet Obesity Management Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pet Obesity Management Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pet Obesity Management Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pet Obesity Management Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pet Obesity Management Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pet Obesity Management Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pet Obesity Management Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pet Obesity Management Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pet Obesity Management Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pet Obesity Management Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pet Obesity Management Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pet Obesity Management Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pet Obesity Management Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pet Obesity Management Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pet Obesity Management Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pet Obesity Management Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pet Obesity Management Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pet Obesity Management Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pet Obesity Management Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pet Obesity Management Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pet Obesity Management Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pet Obesity Management Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pet Obesity Management Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pet Obesity Management Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pet Obesity Management Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis Inc (Pfizer)
  2. 8.1.1 Zoetis Inc (Pfizer) Company Information
  3. 8.1.2 Zoetis Inc (Pfizer) Business Overview
  4. 8.1.3 Zoetis Inc (Pfizer) Pet Obesity Management Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Inc (Pfizer) Pet Obesity Management Product Portfolio
  6. 8.1.5 Zoetis Inc (Pfizer) Recent Developments
  7. 8.2 Novo Nordisk A/S
  8. 8.2.1 Novo Nordisk A/S Company Information
  9. 8.2.2 Novo Nordisk A/S Business Overview
  10. 8.2.3 Novo Nordisk A/S Pet Obesity Management Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk A/S Pet Obesity Management Product Portfolio
  12. 8.2.5 Novo Nordisk A/S Recent Developments
  13. 8.3 Vivaldis
  14. 8.3.1 Vivaldis Company Information
  15. 8.3.2 Vivaldis Business Overview
  16. 8.3.3 Vivaldis Pet Obesity Management Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vivaldis Pet Obesity Management Product Portfolio
  18. 8.3.5 Vivaldis Recent Developments
  19. 8.4 Royal Canin
  20. 8.4.1 Royal Canin Company Information
  21. 8.4.2 Royal Canin Business Overview
  22. 8.4.3 Royal Canin Pet Obesity Management Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Royal Canin Pet Obesity Management Product Portfolio
  24. 8.4.5 Royal Canin Recent Developments
  25. 8.5 Pedigree Petfoods
  26. 8.5.1 Pedigree Petfoods Company Information
  27. 8.5.2 Pedigree Petfoods Business Overview
  28. 8.5.3 Pedigree Petfoods Pet Obesity Management Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pedigree Petfoods Pet Obesity Management Product Portfolio
  30. 8.5.5 Pedigree Petfoods Recent Developments
  31. 8.6 Hill's Pet Nutrition, Inc
  32. 8.6.1 Hill's Pet Nutrition, Inc Company Information
  33. 8.6.2 Hill's Pet Nutrition, Inc Business Overview
  34. 8.6.3 Hill's Pet Nutrition, Inc Pet Obesity Management Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hill's Pet Nutrition, Inc Pet Obesity Management Product Portfolio
  36. 8.6.5 Hill's Pet Nutrition, Inc Recent Developments
  37. 8.7 Auxthera LLC
  38. 8.7.1 Auxthera LLC Company Information
  39. 8.7.2 Auxthera LLC Business Overview
  40. 8.7.3 Auxthera LLC Pet Obesity Management Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Auxthera LLC Pet Obesity Management Product Portfolio
  42. 8.7.5 Auxthera LLC Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research